Analytical Data
-
基因名
APCDD1
-
简介
The APCDD1 protein acts as a negative regulator, cell-autonomously inhibiting the Wnt signaling pathway and upstream of β-catenin. Its proposed mode of action involves interactions with Wnt and LRP proteins, suggesting a role in regulating the Wnt signaling cascade. APCDD1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived APCDD1 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
别名
Apcdd1; Drapc1; B7323; FP7019; HHS; HTS; HYPT1
-
种属
Mouse
-
表达系统
HEK293
-
标签
C-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q3U128
-
表达区间
L27-T492
-
蛋白长度
Extracellular Domain
-
分子量
65-68 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
APCDD1 (Adenomatous Polyposis Coli Down-Regulated 1) is a protein that has garnered significant attention due to its potential role in cancer biology and cellular signaling pathways. Initially identified as a down-regulated gene in colorectal cancer, APCDD1 has been implicated in various physiological processes, including cell proliferation, differentiation, and apoptosis. Its expression patterns suggest a multifaceted role in tumor suppression and developmental regulation, making it a candidate for further investigation in the context of cancer therapy. Research has shown that APCDD1 interacts with the Wnt signaling pathway, which is critical for embryonic development and has been found to be dysregulated in several malignancies. Understanding the structure and function of APCDD1, particularly through recombinant protein studies, is essential for elucidating its molecular mechanisms and exploring its therapeutic potential. By producing and characterizing recombinant APCDD1, researchers aim to uncover its functional properties, interaction partners, and downstream effects on cellular behavior. This knowledge could contribute to the development of innovative strategies for cancer treatment, particularly in targeting the Wnt pathway and its associated networks. Overall, the study of APCDD1 as a recombinant protein presents a promising avenue for advancing our understanding of its biological roles and therapeutic applications in oncology.
